| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Redwood Area Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Redwood Area Hospital is based in Redwood Falls, MN. You can find more information on Redwood Area Hospital at www.redwoodareahospital.org
Premier Health Partners is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Blue Elm is a Westwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health2047 Inc. is a Silicon Valley integrated innovation enterprise whose mission is to develop, guide, and commercialize disruptive ideas that enhance — at the system level— the practice of healthcare.